Literature DB >> 18027906

Niphatoxin C, a cytotoxic tripyridine alkaloid from Callyspongia sp.

Malcolm S Buchanan1, Anthony R Carroll, Rama Addepalli, Vicky M Avery, John N A Hooper, Ronald J Quinn.   

Abstract

As part of our studies to discover P2X 7 receptor antagonists, the sponge Callyspongia sp. was investigated. A new tripyridine alkaloid niphatoxin C ( 1) was isolated and had P2X 7 receptor antagonism; however, cytotoxicity of THP-1 cells was the predominant biological effect at higher concentrations. Its structure was determined by 1- and 2-D NMR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18027906     DOI: 10.1021/np070366q

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Enantioselective total synthesis and structural assignment of callyspongiolide.

Authors:  Arun K Ghosh; Luke A Kassekert; Joseph D Bungard
Journal:  Org Biomol Chem       Date:  2016-12-07       Impact factor: 3.876

2.  Callyspongiolide, a cytotoxic macrolide from the marine sponge Callyspongia sp.

Authors:  Cong-Dat Pham; Rudolf Hartmann; Philip Böhler; Björn Stork; Sebastian Wesselborg; Wenhan Lin; Daowan Lai; Peter Proksch
Journal:  Org Lett       Date:  2013-12-13       Impact factor: 6.005

3.  Enantioselective Synthesis of Both Epimers at C-21 in the Proposed Structure of Cytotoxic Macrolide Callyspongiolide.

Authors:  Arun K Ghosh; Luke A Kassekert
Journal:  Org Lett       Date:  2016-06-22       Impact factor: 6.005

Review 4.  Action of natural products on p2 receptors: a reinvented era for drug discovery.

Authors:  Robson Faria; Leonardo Ferreira; Rômulo Bezerra; Valber Frutuoso; Luiz Alves
Journal:  Molecules       Date:  2012-11-01       Impact factor: 4.411

Review 5.  Metabolities from Marine Sponges of the Genus Callyspongia: Occurrence, Biological Activity, and NMR Data.

Authors:  Lucas Hilário Nogueira de Sousa; Rusceli Diego de Araújo; Déborah Sousa-Fontoura; Fabrício Gava Menezes; Renata Mendonça Araújo
Journal:  Mar Drugs       Date:  2021-11-26       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.